Dr.Anand Burman

Dr. Anand C. Burman is the Chairman of Dabur India Ltd with particular interests in the areas of Research and Development in the Pharmaceutical Sciences as well as Biotechnology and Technology issues. Dr. Burman's education was both multidisciplinary and intemational. His high school education occurred at St. Paul's School in Darjeeling, India and was followed by a B.Sc. in Chemistry from the University of Wisconsin and M.Sc. in Chemistry from the University of Kansas. His Doctorate was in the area of Pharmaceutical Chemistry from the University of Kansas in 1980.

Professionally, he has held many assignments with Dabur Group. He is currently also the Managing Director of Dabur Oncology plc UK, a 100% subsidiary of Dabur Pharma Ltd.

Dr. Anand’s keen interest in Research and Development in the field of Biotechnology and Pharmaceutical Sciences has been instrumental to the growth of the Dabur industry. Before the time Dr. Anand had joined Dabur, it was generating revenue of nearly Rs. 20 crores, but after a decade; in the 1990’s Dabur’s revenue had gone up to Rs. 100 crore.

Dr. Anand realised the enormous growth potential in the field of Ayurvedic medicine and keenly studied the Indian consumer market. So, he devised strategies that would cater to the needs of the Indian consumer in the best possible way.

DABURDabur (Dabur India Ltd.) (derived from Daktar Burman) is the fourth largest Fast Moving Consumer Goods (FMCG) company in India with consolidated Revenues of over INR 7,800 Crores and Market Capitalisation of over INR 46,600 Crore (at the end of 2014-15). Building on a legacy of over 130 years, Dabur is today India’s most trusted name and the world’s largest Ayurvedic medicine & related products manufacturer and Natural Health Care Company. Today, Dabur has a portfolio of over 381 trusted products spread across 21 categories and over 1,000 SKUs. Dabur was founded in 1884 by Dr. S. K. Burman, a physician in West Bengal, to produce and dispense Ayurvedic medicines. Dr. Burman designed Ayurvedic medication for diseases such as cholera and malaria.

Dabur India's FMCG portfolio today includes five flagship brands with distinct brand identities: Dabur as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Réal for fruit-based beverages and Fem for facial bleaches and skin care.

Dabur has also been working towards identifying environmentally sensitive herbs and medicinal plants and developing methodologies to address their sustainability concerns. It also undertakes special training programmes for farmers, villagers and tribal communities across the country to train them on sustainable and environment-friendly cultivation processes.